retatrutide regulatory approval approval: FDA status, clinical trial results, and when it could be available Retatrutide Availability and Current Status:

Endocrinology Diabetes & Metabolism, 7(1)

Unlike tirzepatide, it is a triple agonist , acting on GLP-1, GIP, and glucagon receptors

Clinical trials show probiotics produce modest weight loss of 0.5-2 kg, while FDA-approved medications like semaglutide and tirzepatide demonstrate 15-21% body weight reduction with robust clinical evidence

In some instances, the side effects were serious enough for patients to require medical treatment for symptoms such as nausea, vomiting, diarrhea, abdominal pain, and constipation, the FDA said

In fact, it was Weight Watchers that (inadvertently) taught me to binge eat as a pre-teen